Ignite Creation Date:
2025-12-24 @ 6:33 PM
Ignite Modification Date:
2026-02-23 @ 8:07 PM
Study NCT ID:
NCT02794857
Status:
COMPLETED
Last Update Posted:
2018-05-07
First Post:
2016-05-24
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Safety and Efficacy Study of NP001 in Patients With Amyotrophic Lateral Sclerosis (ALS) and Systemic Inflammation
Sponsor:
Neuraltus Pharmaceuticals, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Amyotrophic Lateral Sclerosis | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | ALS | View |
| None | Amyotrophic Lateral Sclerosis | View |
| None | Motor Neuron Disease | View |
| None | Central Nervous System Diseases | View |
| None | Nervous System Diseases | View |
| None | Neurodegenerative Diseases | View |
| None | Neuromuscular Diseases | View |
| None | Inflammation | View |
| None | C-Reactive Protein | View |